Chicken responses to type I interferon (IFN) have now been defined both in vitro and in vivo.
24–26 July 2017. Churchill College, Cambridge UK
This meeting, building on the success of Emerging Viruses 2015 held in Nottingham, will bring together international researchers with an interest in tackling emerging viruses that affect all species, whether human, pet, production or wild. This will allow cross-fertilisation of ideas and common trends to be identified, as well as discussion of methodologies and prospects going forward.
Ben Peeters et al. (2014) Vaccine 32: 6445–6450. doi.org/10.1016/j.vaccine.2014.09.048
Freely accessible commentary on the project and wider considerations, including production capacity, available in Poultry World (Dick van Doorn, 6 Mar 2017 “Vaccine atomisation promising for influenza immunisation“)
WHO update (10 Mar) – including 2 possible, small human-human-transmission clusters and a Hong Kong case after a visit to mainland China.
Outbreak News Today update (13 Mar) including ECDC map and risk assessment of HPAI mutants
ECDC 6th Rapid Risk Assessment on H7N9 in China (9 Mar)
New Scientist article (21 Feb) on increased number of human H7N9 cases in China this year, with emergence of HPAI derivatives in China & Taiwan
Laurie Garrett’s article (“A Lethal Bird Flu Returns to China“) on H7N9 in China on the Council on Foreign Relations website.
Li M, Liu H, Bi Y, Sun J, Wong G, Liu D et al. (2017). Emerg Infect Dis. Apr [cited 10-Feb-2017]. http://dx.doi.org/10.3201/eid2304.161866
Industry and public-health experts concerned about ramifications of Nagoya Protocol.
Report by Daniel Cressey in Nature, 9 February 2017, with comments by:
John McCauley, director of the Francis Crick Institute Worldwide Influenza Centre in London
Stephen Inglis, former director of the UK’s National Institute for Biological Standards and Control (the Institute’s Influenza Resource Centre play’s important roles in the development of new seasonal and pre-pandemic influenza vaccines)
See “News” (updated 16 Mar 2017)